Sprott, H; Glatzel, M; Michel, B A (2004). Treatment of myositis with etanercept (Enbrel®), a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1. Rheumatology, 43(4):524-526.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | National licences > 142-005 |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Rheumatology
Health Sciences > Pharmacology (medical) |
Language: | English |
Date: | 1 April 2004 |
Deposited On: | 19 Oct 2018 07:19 |
Last Modified: | 26 Jan 2022 18:01 |
Publisher: | Oxford University Press |
ISSN: | 1462-0324 |
OA Status: | Hybrid |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/rheumatology/keh062 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-155534
Download
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 145kB
View at publisher
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 145kB
View at publisher
Article Networks
Authors, Affiliations, Collaborations

UniversitatsSpital Zurich, Zurich, Switzerland
University Hospital Zurich Institute of Neuropathology, Zurich, Switzerland